CME Group Inc. (NASDAQ:CME) CEO Terrence A. Duffy sold 17,375 shares of the firm’s stock in a transaction dated Friday, November 25th. The stock was sold at an average price of $112.58, for a total transaction of $1,956,077.50. Following the sale, the chief executive officer now directly owns 127,739 shares in the company, valued at $14,380,856.62. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Shares of CME Group Inc. (NASDAQ:CME) opened at 111.88 on Tuesday. The stock has a market cap of $37.97 billion, a price-to-earnings ratio of 26.08 and a beta of 0.81. CME Group Inc. has a 1-year low of $81.87 and a 1-year high of $117.80. The stock’s 50 day moving average is $107.19 and its 200-day moving average is $102.98.

CME Group (NASDAQ:CME) last released its earnings results on Thursday, October 27th. The company reported $1.05 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.04 by $0.01. CME Group had a return on equity of 6.90% and a net margin of 41.54%. The company had revenue of $842 million for the quarter, compared to analysts’ expectations of $855.94 million. During the same quarter in the previous year, the business posted $1.02 EPS. The business’s revenue for the quarter was down 1.0% on a year-over-year basis. On average, analysts anticipate that CME Group Inc. will post $4.35 EPS for the current year.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 28th. Shareholders of record on Friday, December 9th will be paid a dividend of $0.60 per share. The ex-dividend date is Wednesday, December 7th. This represents a $2.40 annualized dividend and a yield of 2.15%. CME Group’s dividend payout ratio (DPR) is presently 55.94%.

WARNING: This article was first published by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this article on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark legislation. The original version of this article can be viewed at https://www.thecerbatgem.com/2016/11/29/cme-group-inc-cme-ceo-terrence-a-duffy-sells-17375-shares-of-stock.html.

CME has been the topic of several analyst reports. Deutsche Bank AG raised their price target on shares of CME Group from $111.00 to $112.00 and gave the stock a “buy” rating in a research note on Friday, August 5th. Zacks Investment Research raised shares of CME Group from a “hold” rating to a “buy” rating and set a $116.00 target price on the stock in a research report on Thursday, August 4th. Jefferies Group raised their target price on shares of CME Group from $112.00 to $118.00 and gave the stock a “buy” rating in a research report on Wednesday, August 31st. JPMorgan Chase & Co. set a $116.00 target price on shares of CME Group and gave the stock a “buy” rating in a research report on Monday, September 12th. Finally, RBC Capital Markets set a $92.00 target price on shares of CME Group and gave the stock a “sell” rating in a research report on Friday, October 28th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company’s stock. CME Group presently has a consensus rating of “Hold” and an average target price of $102.89.

A number of institutional investors have recently added to or reduced their stakes in the stock. FMR LLC boosted its stake in shares of CME Group by 86.8% in the second quarter. FMR LLC now owns 6,394,597 shares of the company’s stock valued at $622,833,000 after buying an additional 2,971,686 shares during the last quarter. BlackRock Group LTD boosted its stake in shares of CME Group by 28.7% in the third quarter. BlackRock Group LTD now owns 4,534,689 shares of the company’s stock valued at $473,965,000 after buying an additional 1,010,694 shares during the last quarter. Westfield Capital Management Co. LP purchased a new stake in shares of CME Group during the second quarter valued at approximately $93,330,000. Edgewood Management LLC boosted its stake in shares of CME Group by 20.3% in the second quarter. Edgewood Management LLC now owns 5,482,310 shares of the company’s stock valued at $533,977,000 after buying an additional 923,942 shares during the last quarter. Finally, Kleinwort Benson Investors Dublin Ltd purchased a new stake in shares of CME Group during the second quarter valued at approximately $80,125,000. 79.55% of the stock is currently owned by institutional investors.

About CME Group

CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.

5 Day Chart for NASDAQ:CME

Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.